Changzhou Qianhong Biopharma: Interim financial statements.
Changzhou Qianhong Biopharma: Financial Report for the first half of 2024.
Changzhou Qianhong Biopharma: Announcement on the Extension of the Term of the Company's 2022 Core Employee Stock Ownership Plan
Changzhou Qianhong Biopharma: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.
Changzhou Qianhong Biopharma: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Changzhou Qianhong Biopharma: Legal Opinion of Beijing Dacheng (Nanjing) Law Firm on the 2023 Annual General Meeting of Shareholders of Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
Changzhou Qianhong Biopharma: Announcement on holding an online briefing session on the 2023 Annual Report
Changzhou Qianhong Biopharma: 2024-023 Qianhong Pharmaceutical: Announcement on the company's profit distribution in 2023
Changzhou Qianhong Biopharma: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Changzhou Qianhong Biopharma: 2023 Self-inspection Form for the Implementation of the Company's Internal Control Rules
Changzhou Qianhong Biopharma: Notice of Annual General Meeting of Shareholders
Changzhou Qianhong Biopharma: Shareholders' Meeting Bill Collection
Changzhou Qianhong Biopharma: Profit distribution policy and shareholder return plan for the next three years (2024-2026)
Changzhou Qianhong Biopharma: Internal Control Self-Assessment Report
Qianhong Pharmaceutical: Announcement on the extension of the life period of the first phase of the employee stock ownership plan “Qianhong Pharmaceutical No. 1”
Qianhong Pharmaceutical: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Qianhong Pharmaceutical: Legal Opinion of the 2024 First Extraordinary General Meeting of Shareholders
Qianhong Pharmaceutical: A written commitment to participate in the most recent sole proprietor training (Gao Yuyu)
Qianhong Pharmaceuticals: Constitution Amendments
Qianhong Pharmaceutical: Notice on the Notice of Convening the First Extraordinary General Meeting of Shareholders in 2024
No Data